NCT05664100View on ClinicalTrials.gov

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

April 12, 2023

Study Completion Date

April 12, 2023

Conditions
Hearing Loss, Sensorineural
Interventions
DRUG

FX-345

Single intratympanic injection of FX-345

DRUG

Placebo

Single intratympanic injection of placebo

Trial Locations (4)

29303

Clinical Trial Site, Spartanburg

34239

Clinical Trial Site, Sarasota

78240

Clinical Trial Site, San Antonio

78258

Clinical Trial Site, San Antonio

Sponsors
All Listed Sponsors
lead

Frequency Therapeutics

INDUSTRY